Cancer Biomarkers Are Opportunity To Predict Tumor Response, Relapse Risk
Executive Summary
Oncologic biomarkers could be used to predict tumor response or risk of relapse in certain cancer patients, FDA Deputy Commissioner for Operations Janet Woodcock said March 21